<DOC>
	<DOCNO>NCT00761774</DOCNO>
	<brief_summary>The Sponsor wish develop brivaracetam anti-epileptic treatment subject 16 year old epilepsy . This study permit continued access treatment subject participate previous epilepsy study . The study explore long-term safety efficacy brivaracetam .</brief_summary>
	<brief_title>An Open-label , Multinational , Multicenter , Follow-up Study Evaluate Long-term Safety Efficacy Brivaracetam</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<criteria>Subjects epilepsy participate previous brivaracetam trial allow access present trial . Subjects Investigator believe reasonable potential benefit longterm administration brivaracetam may expect . â€¢ Severe medical , neurological psychiatric disorder , include current suicidal ideation behaviour , laboratory value may impact safety subject , determine investigator .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Epilepsy</keyword>
	<keyword>Monotherapy</keyword>
	<keyword>Partial Onset Seizures</keyword>
</DOC>